← All candidates
Seven insider buys in the last year — $70.16M in all.
49 filings on record.
EVMNEvommune, Inc.
NYSE · Healthcare · $510.99M
$9.99
-4.22% · Sep 15
Seven insider buys in the last year — $70.16M in all.
Nothing in the last fortnight.
Price · 1Y · daily● 7 buys● 9 sells◆ 6 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$510.99M
Float
19.2M
53% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
51.1
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
10% owner
Verduyn-van Weegen Felice Isabel
Bought $25.00M on Nov 7 — 1,562,500 sh @ $16.00, held indirect, 32% of their stake.
1 of 1 position beat the S&P
10% owner
LSP 7 Cooperative UA
Bought $25.00M on Nov 7 — 1,562,500 sh @ $16.00, held direct, 32% of their stake.
1 of 1 position beat the S&P
10% owner
Ra Capital Management, L.p.
Bought $18.51M on Nov 7 — 1,157,096 sh @ $16.00, held indirect, 43% of their stake.
4 of 8 positions beat the S&P
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
44 more transactions on Pro →Context
Wall St
$31.14 avg target
+211.7% vs today · 7 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
1 of 2 quarters beat
Q4 '25−$1.43 act−$0.59
Q3 '25−$8.07 act+$3.29
Coverage
EVMN Stock Tanks as Phase IIb Urticaria Study Misses Primary GoalZacks · 06-30Evommune terminates oral drug’s development in CSUClinical Trials Arena · 06-29Evommune Shares Slide After Phase 2b CSU Trial Misses Main Goal (EVMN)InvestorsHub · 06-29Companies Like Evommune (NYSE:EVMN) Are In A Position To Invest In GrowthSimply Wall St. · 05-11
The file stays open
49 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice